Vocational Rehabilitation and Return to Work in Patients With Chronic Pain: a Randomised Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Pain
- Sponsor
- Uppsala University
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Return to work
- Status
- Terminated
- Last Updated
- 2 years ago
Overview
Brief Summary
This study aims to evaluate whether a vocational behaviour change ability programme has any additional effect on return to work compared with return to work coordination only in persons with chronic pain.
Detailed Description
New vocational rehabilitation models including the workplace are urgently needed for persons with chronic pain. Return to work coordination means external and internal coordination regarding sick leave by help of a rehabilitation coordinator from health care. The goal is to establish a common return to work plan between employer and employee as dictated by Swedish law. The hypothesis is that return to work coordination is not sufficient. Additional effects on return to work and work ability from a behaviour change ability programme aiming to enhance work ability by targeting context at the workplace, physical and psychological functioning, and behavioral skills at work are expected. The hypothesis is tested in a randomised controlled trial. Before the start of the trial a series of 3-6 experimental single case studies will be performed to study the implementation of the interventions more thoroughly.
Investigators
Pernilla Asenlof
Professor
Uppsala University
Eligibility Criteria
Inclusion Criteria
- •Chronic pain with a duration for more than 3 months
- •On sick-leave 25%-100% from salaried employment or studies, for at least 30 days
- •Identified employer or director of studies
- •Ability to understand, speak, and write Swedish
Exclusion Criteria
- •Severe substance use disorder
- •Severe psychiatric illness
- •Recruited participants with employers who does not consent to participate
Outcomes
Primary Outcomes
Return to work
Time Frame: Number of days during a 12-month period from baseline to 12 months post baseline.
Average sick leave according to the Swedish Social Insurance registry, defined as net days.
Work ability
Time Frame: 12 months
Self-report. Work Ability Index (WAI). The questionnaire covers 7 dimensions: 1. current work ability compared with lifetime best 2. work ability in relation to the demands of the job 3. number of diagnosed illnesses or limiting conditions 4. estimated impairment owing to diseases/illnesses or limiting conditions 5. amount of sick leave during the last year 6. prognosis of work ability in 2 years' time 7. psychological resources. The dimensions have different scores. A total index is computed ranging from 7 to 49, where higher scores indicate higher work ability.
Secondary Outcomes
- Short-term sick leave < 2 weeks, number of days(6 months, 12 months, 24 months)
- Work Ability(Baseline, 6 months, 24 months)
- Return to work(Baseline, 6 months, 24 months)
- Opioid use(Baseline, 6 months, 12 months, 24 months)
- Pain interference: The Brief Pain Inventory(Baseline, 6 months, 12 months, 24 months)
- Health-related quality of life: EQ-5D(Baseline, 6 months, 12 months, 24 months)
- Substance use disorder(Baseline, 6 months, 12 months, 24 months)
- Pain severity: The Brief Pain Inventory(Baseline, 6 months, 12 months, 24 months)
- Balance(Baseline, 6 months, 12 months)
- Functional lifting capacity(Baseline, 6 months, 12 months)
- Fear of movement and reinjury(Baseline, 6 months, 12 months)
- Experience of injustice(Baseline, 6 months, 12 months)
- Physical activity level(Baseline, 6 months, 12 months)
- Catastrophizing(Baseline, 6 months, 12 months)
- Depressive symptoms(Baseline, 6 months, 12 months, 24 months)
- Generalised Anxiety Disorder(Baseline, 6 months, 12 months, 24 months)
- Grip strength(Baseline, 6 months, 12 months)
- Psychological inflexibility in pain(Baseline, 6 months, 12 months)
- Sleep(Baseline, 6 months, 12 months)
- Global goal achievement(6 months, 12 months, 24 months)
- Explorative identification of change in biomarkers(Changes from baseline to 6 months.)
- Cognitive function(Baseline, 6 months, 12 months)